日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection

PARP1介导的ADP核糖基化全局重塑抑制甲型流感病毒感染

Zhang, Zhenyu; Uribe, Isabel; Davis, Kaitlin A; McPherson, Robert L; Larson, Gloria P; Badiee, Mohsen; Tran, Vy; Ledwith, Mitchell P; Feltman, Elizabeth M; Yú, Shuǐqìng; Caì, Yíngyún; Chang, Che-Yuan; Yang, Xingyi; Ma, Zhuo; Chang, Paul; Kuhn, Jens H; Leung, Anthony K L; Mehle, Andrew

Interferon-induced PARP14-mediated ADP-ribosylation in p62 bodies requires the ubiquitin-proteasome system.

p62 体中干扰素诱导的 PARP14 介导的 ADP 核糖基化需要泛素-蛋白酶体系统

Raja Rameez, Biswas Banhi, Abraham Rachy, Wang Yiran, Chang Che-Yuan, Hendriks Ivo A, Buch-Larsen Sara C, Liu Hongrui, Yang Xingyi, Wang Chenyao, Vu Hien, Hamacher-Brady Anne, Cai Danfeng, Leung Anthony K L

Early- vs. late-onset colon cancer: clinicopathological insights and survival outcomes in an East Asian cohort

早发型与晚发型结肠癌:东亚人群的临床病理学见解和生存结果

Lin, Chun-Chi; Chang, Che-Yuan; Lin, Yu-Zu; Cheng, Hou-Hsuan; Huang, Sheng-Chieh; Lin, Hung-Hsin; Lan, Yuan-Tzu; Wang, Huann-Sheng; Chang, Shih-Ching; Yang, Shung-Haur; Jiang, Jeng-Kai; Chen, Wei-Shone; Teng, Hao-Wei; Yang, Yi-Wen

Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer

在难治性转移性结直肠癌中,中等剂量的贝伐珠单抗与TAS-102联合使用可延长无进展生存期。

Tseng, Kuan-Yu; Yang, Mu-Ying; Chen, Wei-Shone; Jiang, Jeng-Kai; Wang, Huann-Sheng; Chang, Shih-Ching; Lan, Yuan-Tzu; Lin, Chun-Chi; Lin, Hung-Hsin; Huang, Sheng-Chieh; Cheng, Hou-Hsuan; Yang, Yi-Wen; Lin, Yu-Zu; Chang, Che-Yuan; Teng, Hao-Wei

Recent Advances In Silicon Carbide Chemical Mechanical Polishing Technologies

碳化硅化学机械抛光技术的最新进展

Hsieh, Chi-Hsiang; Chang, Che-Yuan; Hsiao, Yi-Kai; Chen, Chao-Chang A; Tu, Chang-Ching; Kuo, Hao-Chung

Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels

代谢综合征患者血清中分泌粒蛋白 III 浓度升高,且与空腹血糖水平独立相关

Chun-Chung Lin, Kai-Pi Cheng, Hao-Chang Hung, Chung-Hao Li, Ching-Han Lin, Chih-Jen Chang, Che-Yuan Hu, Hung-Tsung Wu, Horng-Yih Ou0